Vitamin D deficiency in relation to the risk of metabolic syndrome in middle-aged and elderly patients with type 2 diabetes mellitus

Journal of Nutritional Science and Vitaminology

Volumn 62, Issue 4, 2016, Pages 213-219

  Pan, Guo Tao ^a   Guo, Jian Feng ^a   Mei, Shao Lin ^b   Zhang, Meng Xi ^a   Hu, Zhi Yong ^b   Zhong, Chong Ke ^a   Zeng, Chang You ^b   Liu, Xiao Hong ^b   Ma, Qing Hua ^c   Li, Bing Yan ^a   Qin, Li Qiang ^a   Zhang, Zeng Li ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Center of Disease Control and Prevention   (China)

^c The Third People s Hospital of Xiangcheng District   (China)

Author keywords

Deficiency; Metabolic syndrome; Type 2 diabetes mellitus; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIP CIRCUMFERENCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; PREVALENCE; RISK FACTOR; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; AGED; ANALOGS AND DERIVATIVES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BLOOD PRESSURE; CHINA; COMPLICATION; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHINA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; TRIGLYCERIDES; VITAMIN D; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

EID: 84991248558     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.62.213     Document Type: Article

References (33)

1. Holick MF. 2007. Vitamin D deficiency. N Engl J Med 357: 266-281.
2. Boucher BJ. 2011. Vitamin D insufficiency and diabetes risks. Curr Drug Targets 12: 61-87.
3. Talaei A, Mohamadi M, Adgi Z. 2013. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr 5: 8.
4. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. 2008. The metabolic syndrome. Endocr Rev 29: 777-822.
5. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
6. Karhapaa P, Pihlajamaki J, Porsti I, Kastarinen M, Mustonen J, Niemela O, Kuusisto J. 2010. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med 268: 604-610.
7. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K. 2007. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167: 1159-1165.
8. Ford ES, Ajani UA, McGuire LC, Liu S. 2005. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28: 1228-1230.
9. Pitsavos C, Panagiotakos DB, Skoumas J, Papadimitriou L, Stefanadis C. 2008. Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA study. Angiology 59: 335-341.
10. Badawi A, Klip A, Haddad P, Cole DE, Bailo BG, El- Sohemy A, Karmali M. 2010. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes 3: 173-186.
11. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G. 2009. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev: CD006612.
12. Kadoglou NP, Avgerinos ED, Liapis CD. 2010. An update on markers of carotid atherosclerosis in patients with Type 2 diabetes. Biomark Med 4: 601-609.
13. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM. 2010. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 152: 307-314.
14. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, Liu H, Lane MA, Mullan RJ, Hazem A, Erwin PJ, Hensrud DD, Murad MH, Montori VM. 2011. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 96: 1931-1942.
15. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 2012. 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 32: 2794-2802.
16. Knekt P, Laaksonen M, Mattila C, Harkanen T, Marniemi J, Heliovaara M, Rissanen H, Montonen J, Reunanen A. 2008. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19: 666-671.
17. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. 2008. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57: 2619-2625.
18. Alberti KG, Zimmet PZ. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
19. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. 2008. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122: 398-417.
20. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. 2011. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911-1930.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
22. Wallace TM, Levy JC, Matthews DR. 2004. Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495.
23. Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Fenger M, Linneberg A. 2012. Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population. Cardiology 123: 62-70.
24. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Ger stein HC, Perkins BA, Harris SB, Zinman B, Hanley AJ. 2010. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 33: 1379-1381.
25. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. 2002. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51: 1367-1374.
26. Kim J. 2015. Association between serum vitamin D, parathyroid hormone and metabolic syndrome in middle- aged and older Korean adults. Eur J Clin Nutr 69: 425-430.
27. Kim S, Lim J, Kye S, Joung H. 2012. Association between vitamin D status and metabolic syndrome risk among Korean population: based on the Korean National Health and Nutrition Examination Survey IV-2, 2008. Diabetes Res Clin Pract 96: 230-236.
28. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R. 2009. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89: 1321-1327.
29. Cho HJ, Kang HC, Choi SA, Ju YC, Lee HS, Park HJ. 2005. The possible role of Ca21 on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biol Pharm Bull 28: 1418-1423.
30. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. 2000. Regulation of adiposity by dietary calcium. FASEB J 14: 1132-1138.
31. Kimura Y, Kawamura M, Owada M, Oshima T, Murooka M, Fujiwara T, Hiramori K. 1999. Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity. Intern Med 38: 31-35.
32. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. 2008. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alphahydroxylase knockout mice. Kidney Int 74: 170-179.
33. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. 2007. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017-2029.